Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

biOasis advances lysosomal storage disease program

Sep. 12, 2014

Hyperion Therapeutics terminates development of DiaPep277 following evidence of misconduct

Sep. 10, 2014

Once-weekly Bydureon Pen launched in U.S. for adults with type 2 diabetes

Sep. 9, 2014

First animal model of CLN7 disease described

Sep. 9, 2014

Lilly's insulin peglispro shows HbA1c superiority over insulin glargine in type 1 diabetes

Sep. 8, 2014

Sirona Biochem reports preclinical data for SBM-TFC-039

Sep. 8, 2014

Levomepromazine proves safe and effective for the management of distressing NEMD in MPS III

Sep. 5, 2014

Capstone Therapeutics reports phase Ia results for AEM-28

Sep. 5, 2014

Ryzodeg launched in first country

Sep. 4, 2014

FDA grants orphan drug status to Genz-682452 for Fabry's disease

Sep. 4, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...